Mr Neil Finlayson

Neil joined Brisbane based DNA vaccine developer Admedus Immunotherapies as CEO in February 2011.  He was formerly Business Development Director of Bio Innovation SA in Adelaide.

Neil has extensive experience in banking and finance, JVs, partnering and licensing, and in company formations.  During his career, Neil has licensed technologies to national and international biotech and pharmaceutical companies and been instrumental in the formation of 17 start-up companies.

Neil has previously held positions as CEO of Vaccine Solutions Pty Ltd (co-owned by CSL Limited and the Queensland Institute of Medical Research), Director of AbRegen Pty Ltd (a biotech company he helped establish) and Executive Officer of the Cooperative Research Centre for Vaccine Technology (a $42M joint venture). He began his career in banking and finance with Westpac Banking Corporation.